As biotechnology continues to grow and evolve GEN remains committed to staying on top of new developments and significant trends that impact the global biotech industry. We have always worked with our editorial and scientific advisory board to help us accomplish this mission. Our board members are involved in pioneering life science R&D and technology advances as well as in pushing the capabilities of biomanufacturing processes.

It is with great pride that GEN has decided to expand its editorial and scientific advisory board.

“Our new members come with extensive experience in product and technology development and most are company presidents and CEOs who bring a wealth of strategic business expertise that is not only critical for the success of their respective companies but which can also help GEN address the broader commercial trajectory of the international bioindustry,” said John Sterling, Editor in Chief, GEN.

Our new members are:

Peter Banks, Ph.D., Scientific Director, BioTek Instruments
Roslyn Brandon, D.V.M., Ph.D., President and CEO, Immunexpress
Robert Clarke, Ph.D., President & CEO, Pulmatrix
Rick Gonzalez, President and CEO, Navidea Biopharmaceuticals
Harry E. Gruber, M.D., CEO, Tocagen
Andrew Hirsch, President and CEO, Bind Therapeutics
Jin Seok Hur, Ph.D., Technology Director, Novasep
Anis H. Khimani, Ph.D., Head of Strategy & Marketing, Research Reagent Solutions, PerkinElmer
Peter Levison, Senior Marketing Director – Downstream Processing, Pall Life Sciences,
Jan Lichtenberg, Ph.D., CEO and Co-Founder, InSphero
Miodrag Micic, Sc.D., Ph.D., Professor and Department Chairman, Dept. of Engineering Design Technology and Dept of New Products Development, Cerritos College

They join current board members, including:

Pete Gagnon, Bioprocessing Technology Institute, Singapore
Uwe Gottschalk, Ph.D., Lonza Pharma & Biotech
James Inglese, Ph.D., National Center for Advancing Translational Sciences
Mikael Kubista, Ph.D., Biotechnology Institute, Czech Republic
Eric Schadt, Ph.D., Icahn School of Medicine at Mount Sinai
Zhiwei Song, Ph.D., National University of Singapore
Sumio Sugano, M.D., Ph.D., University of Tokyo
John Talley, Ph.D., SARmont
Bin Wang, Ph.D., Fudan University Shanghai Medical College
Daniel Wang, Ph.D., MIT

Previous articleAffymetrix to Consider Revised Origin Offer
Next articleJobWatch: Training the Next Generation of Ph.D.’s